Unifesp - Hospital Sao Paulo

São Paulo 04038-002

1 studies enrolling now · 4 studies all time

What they study most

C3 Glomerulonephritis, C3 Glomerulopathy, C3G, Cardiovascular Diseases, Complement 3 Glomerulonephritis, Complement 3 Glomerulopathy, Complement 3 Glomerulopathy (C3G), Coronary Artery Disease, Coronary Disease, DDD, DME, Dense Deposit Disease

Studies at this site

• CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME — Recruiting now
• Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis — Completed
• International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) — Completed
• Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function — Completed